http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CZ-20004097-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73e8bd115a70d1b93335488e77f0587d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d769bf13954f0668d98efb87937e40a |
| publicationDate | 2001-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CZ-20004097-A3 |
| titleOfInvention | Oral dosage forms with reproducible release of the active ingredients gatifloxacin or pharmaceutically acceptable salts or hydrates thereof |
| abstract | The present invention relates to a solid multiparticulate dosage form for use in a pharmaceutical compositionnoral administration containing or including gatifloxacinnpharmaceutically acceptable salts or hydrates and excipientsnfrom the group comprising fillers, binders, lubricants and substancesndisintegrating agents or mixtures thereof, wherein the internal phasencontains the active ingredient gatifloxacin or a pharmaceutically acceptable salt thereofnuseful salts or hydrates together with excipientsna group of fillers, binders, disintegrants, ornmixtures thereof and that it contains at least one external phase,nnecessarily consisting of at least one disintegrant andnother excipients from the group consisting of at least onena lubricant, optionally fillers and / or optionally binders, as well asnmethod of its production. |
| priorityDate | 1999-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 33.